probably.
But the size of the potential market that cardiocel and other applications of adapt technology can be used for, and has a very good chance of becoming the product of choice.
There are in excess of 200 thousand cardiothoracic procedures performed in the USA that are all potential uses of cardiocel ( I recall reading somewhere that patches were used to close pericardium, so cases that don't require a patch could end up requiring one). We may not gain complete uptake by all for all procedures, but there is every possibility that we can.
Selling 200 000+ patches to the US each year for cardiothoracic uses alone...... yeah, I may be dreaming - almost delusional, but in the absence of any evidence that shows that we can not achieve this, I will continue to dream of what could be (and be happy if we only get part of the way).
Cormatrix reported selling to almost 850 centres across the states..... I don't see why AHZ can not achieve the same, with a product reported to be of superior quality.
Dreaming on!
- Forums
- ASX - By Stock
- AVR
- Quarterly
Quarterly, page-162
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.90 |
Change
-0.100(0.56%) |
Mkt cap ! $342.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $11.68K | 651 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | $17.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.99 | 39 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 17.750 |
1 | 26 | 17.660 |
1 | 26 | 17.650 |
1 | 150 | 17.600 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.990 | 39 | 3 |
18.000 | 354 | 3 |
18.010 | 35 | 2 |
18.030 | 14 | 1 |
18.050 | 300 | 1 |
Last trade - 11.14am 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |